Pharma Journalist 9038 posts 0 comments

InMed Pharmaceuticals Inc. reported completed enrollment in its first Phase 1 clinical trial with INM-755 in healthy subjects (Study 755-101-HV). INM-755 is a CBN cream intended as a…
Read More...

Phio Pharmaceuticals Corp. a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL) therapeutic…
Read More...

The FDA has been added to the agenda for Smithers' 9th Extractables and Leachables USA Conference, taking place in Bethesda, MD, April 20-22, 2020. Alan Hood, Research Toxicologist…
Read More...

Novavax, Inc. a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced that the Coalition for Epidemic Preparedness Innovations…
Read More...

SMi Reports: There will be a workshop surrounding ‘Developing apps for Connected Drug Delivery’ for Injectable Drug Delivery 2020 The Injectable Drug Delivery conference will…
Read More...

COVID-19 Therapeutics Accelerator will coordinate R&D efforts and remove barriers to drug development and scale-up to address the epidemic The Bill & Melinda Gates…
Read More...

Today, AnaBios announced a Research Collaboration Agreement (RCA) with the U.S. Food and Drug Administration (FDA) to study adult human primary cardiomyocytes as a reference for…
Read More...

Zydus Cadila, an innovation-driven global pharmaceutical company, and XOMA Corporation announced they have entered into a licensing agreement to advance an IL-2-based immuno-oncology…
Read More...

Nanoform, an innovative nanoparticle medicine enabling company, and Orion Corporation, a Finnish pharmaceutical company, announced a collaboration to apply Nanoform's award-winning CESS…
Read More...

ViiV Healthcare and the University of North Carolina at Chapel Hill announced a five-year, $20 million renewal of a unique, public-private research partnership solely focused on…
Read More...